What is left when anti-tumour necrosis factor therapy in inflammatory bowel diseases fails?
about
Characterizing unmet medical need and the potential role of new biologic treatment options in patients with ulcerative colitis and Crohn's disease: a systematic review and clinician surveysDiterpenoid alkaloids of Aconitum laciniatum and mitigation of inflammation by 14-O-acetylneoline in a murine model of ulcerative colitis.Early investigational TNF receptor antagonists for the treatment of ulcerative colitis.Redox cycling of Cu(II) by 6-mercaptopurine leads to ROS generation and DNA breakage: possible mechanism of anticancer activity.
P2860
What is left when anti-tumour necrosis factor therapy in inflammatory bowel diseases fails?
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
What is left when anti-tumour ...... ammatory bowel diseases fails?
@en
type
label
What is left when anti-tumour ...... ammatory bowel diseases fails?
@en
prefLabel
What is left when anti-tumour ...... ammatory bowel diseases fails?
@en
P2860
P356
P1476
What is left when anti-tumour ...... ammatory bowel diseases fails?
@en
P2093
Ian C Lawrance
P2860
P304
P356
10.3748/WJG.V20.I5.1248
P407
P577
2014-02-01T00:00:00Z